| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), LGVN's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.61M | - | - | |
| CFO | 443.2K | $323.1K | - | |
| Dir | 262.0K | - | - | |
| CEO | 125.6K | $74.5K | - | |
| Other | 83.9K | $217.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2025 | Locklear Lisa | Chief Financial Officer | Buy | 11,766 | $0.00 | - | +4.9% | +6.8% | -0.4% | |
| Aug 11, 2025 | Baluch Khoso | Director | Buy | 11,766 | $0.00 | - | +28.9% | +6.8% | -0.4% | |
| May 30, 2025 | Soffer Rock71 | Director | Sell | 21,000 | $1.27 | $26,750.00 | -9.1% | -33.1% | - | |
| May 22, 2025 | Soffer Rock71 | Director | Sell | 2,000 | $1.32 | $2,640.00 | -0.9% | -41.8% | -40.4% | |
| May 16, 2025 | Hare Joshua73 | Chief Scientific Officer | Sell | 5,250 | $1.40 | $7,367.33 | -0.7% | -46.8% | - | |
| Dec 2, 2024 | Baluch Khoso | Director | Sell | 1,250 | $2.07 | $2,588.13 | -5.0% | -33.0% | -68.7% | |
| Apr 11, 2024 | Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Buy | 10,638 | $2.35 | $24,999.30 | +118.5% | +125.2% | -26.2% | |
| Apr 11, 2024 | Hare Joshua73 | Chief Scientific Officer | Buy | 148,936 | $2.35 | $349,999.60 | +30.8% | +125.2% | -26.2% | |
| Apr 11, 2024 | Soffer Rock71 | Director | Buy | 138,298 | $2.35 | $325,000.30 | +196.9% | +125.2% | -26.2% | |
| Jan 10, 2024 | Ross Cathy | Director | Buy | 5,000 | $1.31 | $6,544.50 | +100.0% | -83.3% | -86.0% |